Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Scynexis Inc
(NQ:
SCYX
)
1.890
-0.010 (-0.53%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 25, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Scynexis Inc
< Previous
1
2
3
4
5
6
Next >
Looking Into SCYNEXIS's Return On Capital Employed
April 03, 2023
Via
Benzinga
Dow Rises 100 Points; Accelerate Diagnostics Shares Spike Higher
March 30, 2023
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining around 100 points on Thursday. The Dow traded up 0.31% to 32,819.16 while the NASDAQ rose 0.63% to 12,001.83. The S&P...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
March 30, 2023
Via
Benzinga
Scynexis Inc. (NASDAQ: SCYX) Leading the Way in Thursday Trading Based on Percentage Gain
March 30, 2023
Via
Investor Brand Network
SCYNEXIS (NASDAQ: SCYX) Enters Into Exclusive Agreement with GSK (NYSE: GSK) to Continue Commercializing Brexafemme to Treat Fungal Infections
March 30, 2023
SCYNEXIS, Inc. (NASDAQ: SCYX) operates as a biotechnology company, which is focused on the research and development of novel solutions
Via
Spotlight Growth
GSK Bets On Scynexis' FDA-Approved Antifungal Drug For Over $500M In Bio Bucks
March 30, 2023
Via
Benzinga
SCYNEXIS's Return On Capital Employed Overview
December 13, 2022
Via
Benzinga
Scynexis Looks For Commercial Partner For Its Lead Infection Treatment
October 20, 2022
Via
Benzinga
Why Bed Bath & Beyond Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
March 30, 2023
Gainers SCYNEXIS, Inc. (NASDAQ: SCYX) shares climbed 68% to $2.8184 after the company announced an exclusive license agreement with GSK for Brexafemme, in which the company will receive an upfront...
Via
Benzinga
Warner Music Layoffs: What to Know About the Latest WMG Job Cuts
March 30, 2023
Warner Music (WMG) layoffs have the entertainment company cutting 4% of its workforce, or 270 jobs, during economic uncertainty.
Via
InvestorPlace
Why Is EVgo (EVGO) Stock Up 25% Today?
March 30, 2023
EVgo (EVGO) stock is on the rise Thursday following the release of its earnings report for the fourth quarter of the year!
Via
InvestorPlace
Why Is Scynexis (SCYX) Stock Up 69% Today?
March 30, 2023
Scynexis (SCYX) stock is taking off on Tuesday as investors react to news of an exclusive license agreement for Brexafemme.
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
March 30, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
March 27, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
March 22, 2023
Via
Benzinga
Analyst Sees Multiple Chances With Over 300% Upside Potential For This Fungal Infections Stock
March 01, 2023
Via
Benzinga
Why Edible Garden Shares Are Trading Lower By Over 26%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
March 22, 2023
Gainers Maxpro Capital Acquisition Corp. (NASDAQ: JMAC) shares jumped 69.6% to $15.01 after dropping 24% on Tuesday.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
March 01, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 1, 2023
March 01, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
February 06, 2023
We're starting off the week with an overview of the biggest pre-market stock movers traders need to know about for Monday!
Via
InvestorPlace
Stocks That Hit 52-Week Lows On Friday
December 30, 2022
Friday's session saw 75 companies set new 52-week lows.
Via
Benzinga
Provention Bio's Second Try, Apellis's Eye Disorder Drug Review, 3 Adcom Verdicts And More: November's Key PDUFA Catalysts Biotech Investors Must Know
November 01, 2022
October proved to be a mixed month for the Food and Drug Administration’s regulatory decisions. Two new molecular entities, or NMEs, were approved during the month, bringing the tally for the...
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
December 28, 2022
On Wednesday, 258 companies hit new 52-week lows.
Via
Benzinga
Looking Into SCYNEXIS's Return On Capital Employed
September 09, 2022
Benzinga Pro data, SCYNEXIS (NASDAQ:SCYX) reported Q2 sales of $1.32 million. Earnings fell to a loss of $13.35 million, resulting in a 144.82% decrease from last quarter.
Via
Benzinga
Important Biotech Catalysts For September 8, 2022 - End Of The Day Summary
September 08, 2022
Via
Benzinga
Earnings Scheduled For August 15, 2022
August 15, 2022
Companies Reporting Before The Bell • Edible Garden (NASDAQ:EDBL) is likely to report earnings for its second quarter.
Via
Benzinga
Recap Of Monday's Biotech Catalysts - End Of the Day Summary
August 01, 2022
Via
Benzinga
SCYNEXIS Shares Climb As FDA Accepts Filing For Vaginal Yeast Infection Candidate Under Priority Review
August 01, 2022
SCYNEXIS (NASDAQ: SCYX) announced that the U.S. Food and Drug Administration (FDA) has accepted its submission of a supplemental New Drug Application (sNDA) to expand the label of BREXAFEMME...
Via
Benzinga
Why Baker Hughes Shares Dropped 8%; Here Are 64 Biggest Movers From Yesterday
July 21, 2022
Gainers Pagaya Technologies Ltd. (NASDAQ: PGY) shares climbed 129.6% to close at $6.20 on Wednesday. Pagaya Technologies is expected to announce its Q2 earnings on August 16, 2022.
Via
Benzinga
This Communication Services Stock Is Trading Higher By Over 82%, Here Are 45 Stocks Moving In Wednesday's Mid-Day Session
July 20, 2022
Gainers Direct Digital Holdings, Inc. (NASDAQ: DRCT) shares surged 82.2% to $2.6787. Direct Digital Holdings said its supply-side advertising platform, Colossus SSP, reported a 540% year-over-year...
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.